Literature DB >> 25022209

Neuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neurons.

Yoshihiko Nakatani1, Minoru Tsuji2, Taku Amano3, Kazuya Miyagawa4, Hiroko Miyagishi4, Atsumi Saito4, Taro Imai4, Kotaro Takeda4, Daisuke Ishii4, Hiroshi Takeda2.   

Abstract

Yokukansan, a traditional Japanese herbal medicine, has been used for the management of neurodegenerative disorders and for the treatment of neurosis, insomnia, and behavioral and psychological symptoms of dementia. Recently, several studies have shown that yokukansan has a neuroprotective effect. The aim of this study was to examine the neuroprotective effect of yokukansan on hippocampal neurons from embryonic mouse brain against the effects of corticosterone, which is considered to be a stress hormone and to be cytotoxic toward neurons. The cell survival rates were measured by the WST-8 assay and LDH assay. Twenty-four hours after treatment with corticosterone, cell numbers were significantly decreased compared with the control or treatment with vehicle in a dose-dependent manner. When cells were treated with 30 μM corticosterone, the decrease in the number of cells was significantly recovered by treatment with yokukansan (100-1,000 μg/ml) in a dose-dependent manner. However, yokukansan did not suppress the decrease in cell numbers that was induced by treatment with 100 μM corticosterone. In the LDH assay, treatment with yokukansan at a high concentration (500-1,000 μg/ml) suppressed the LDH concentration induced by treatment with both 30 μM and 100 μM corticosterone compared to treatment with corticosterone alone, respectively. These results suggest that yokukansan protects against the cytotoxic effect of a low concentration of corticosterone on hippocampal neurons.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Corticosterone; Hippocampal neuron; WST-8 assay; Yokukansan (Japanese herbal medicine)

Mesh:

Substances:

Year:  2014        PMID: 25022209     DOI: 10.1016/j.phymed.2014.06.004

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.

Authors:  Taichi Nomura; Yoshio Bando; Hua You; Tatsuhide Tanaka; Shigetaka Yoshida
Journal:  Neurochem Res       Date:  2017-09-19       Impact factor: 3.996

2.  Corticosterone Induced the Increase of proBDNF in Primary Hippocampal Neurons Via Endoplasmic Reticulum Stress.

Authors:  Yu Liu; Guang-Jing Zou; Bo-Xuan Tu; Zhao-Lan Hu; Cong Luo; Yan-Hui Cui; Yang Xu; Fang Li; Ru-Ping Dai; Fang-Fang Bi; Chang-Qi Li
Journal:  Neurotox Res       Date:  2020-05-06       Impact factor: 3.911

3.  Yokukansan enhances the proliferation of B65 neuroblastoma.

Authors:  Yoshihiko Nakatani; Taku Amano; Hikaru Yamamoto; Norio Sakai; Minoru Tsuji; Hiroshi Takeda
Journal:  J Tradit Complement Med       Date:  2016-02-22

Review 4.  Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.

Authors:  Kazushige Mizoguchi; Yasushi Ikarashi
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

5.  Neurotherapy of Yi-Gan-San, a Traditional Herbal Medicine, in an Alzheimer's Disease Model of Drosophila melanogaster by Alleviating Aβ42 Expression.

Authors:  Ming-Tsan Su; Yong-Sin Jheng; Chen-Wen Lu; Wen-Jhen Wu; Shieh-Yueh Yang; Wu-Chang Chuang; Ming-Chung Lee; Chung-Hsin Wu
Journal:  Plants (Basel)       Date:  2022-02-21

Review 6.  Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment.

Authors:  Chujun Deng; Huize Chen; Zeyu Meng; Shengxi Meng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

7.  Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.

Authors:  Xiaolie He; Yanjing Zhu; Mei Wang; Guoxin Jing; Rongrong Zhu; Shilong Wang
Journal:  Int J Nanomedicine       Date:  2016-10-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.